LY3143921 hydrate |
| Katalog-Nr.GC25593 |
LY3143921 hydrate is an orally administered ATP-competitive CDC7 inhibitor.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1627696-53-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
LY3143921 hydrate is an orally administered ATP-competitive CDC7 inhibitor.
[1] Peter F. Gallagher, et al. Journal of Clinical Oncology. Volume 37, Issue 15_suppl.
Review for LY3143921 hydrate
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for LY3143921 hydrate
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *